CURRENT PHARMACEUTICAL DESIGN, cilt.23, sa.31, ss.4609-4619, 2017 (SCI-Expanded)
Background: Heart failure (HF) is a global health problem. Like most chronic diseases, HF also courses with acute exacerbations, which have been found to be associated with significant morbidity and mortality. A substantial proportion of acute decompensated heart failure (ADHF) patients clinically present with volume overload.